SummitTX Capital’s ResMed RMD Stock Holding History

SummitTX Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,478	Closed	-$1.23M	–	930
2025 Q3	$1.23M	Buy	4,478 +213	+5%	+$58.2K	0.05%	343
2025 Q2	$1.1M	Sell	4,265 -3,352	-44%	-$800K	0.05%	354
2025 Q1	$1.71M	Buy	+7,617	New	+$1.78M	0.07%	279

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SummitTX Capital's RMD Position: Q4 2025 in Review

SummitTX Capital sold out of ResMed (RMD) in Q4 2025, closing a stake of 4,478 shares — an estimated $1.23M sold.

SummitTX Capital first reported a position in RMD in Q1 2025 and held it in 3 quarters. The position peaked at $1.71M in Q1 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

SummitTX Capital reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 4,478 ResMed shares in Q4 2025, an estimated $1.23M.
SummitTX Capital first reported a position in ResMed in Q1 2025 and held it in 3 quarters.
SummitTX Capital's ResMed position peaked at $1.71M in Q1 2025.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.